Sangamo Therapeutics Inc (NASDAQ: SGMO) – Suitable For Long Term Buy?
Currently, there are 245.40M common shares owned by the public and among those 237.34M shares have been available to trade. The company’s stock has a 5-day price change of 2.76% and -40.94% over the past three months. SGMO shares are trading 14.05% year to date (YTD), with the 12-month market performance down to -49.63% lower. […]
Value Hunters: Look To Sangamo Therapeutics Inc (SGMO)
Currently, there are 245.40M common shares owned by the public and among those 237.58M shares have been available to trade. The company’s stock has a 5-day price change of 3.02% and -48.05% over the past three months. SGMO shares are trading -49.48% year to date (YTD), with the 12-month market performance down to -12.91% lower. […]
Reassessing The Changing Outlook For Sangamo Therapeutics Inc (SGMO)
Currently, there are 245.40M common shares owned by the public and among those 237.58M shares have been available to trade. The company’s stock has a 5-day price change of 10.40% and -41.82% over the past three months. SGMO shares are trading -50.96% year to date (YTD), with the 12-month market performance down to -8.25% lower. […]
Institutional Exposure To Sangamo Therapeutics Inc (SGMO)
Sangamo Therapeutics Inc (SGMO) concluded trading on Wednesday at a closing price of $0.50, with 4.25 million shares of worth about $2.12 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -75.61% during that period and on May 21, 2025 the price saw a […]
Sangamo Therapeutics Inc (SGMO): Street Finally Waking Up
Currently, there are 225.36M common shares owned by the public and among those 219.12M shares have been available to trade. The company’s stock has a 5-day price change of -24.84% and -59.65% over the past three months. SGMO shares are trading -54.90% year to date (YTD), with the 12-month market performance down to -12.11% lower. […]
Now Is A Suitable Moment For A Long-Term Purchase Of Sangamo Therapeutics Inc (NASDAQ: SGMO)
Currently, there are 224.71M common shares owned by the public and among those 214.84M shares have been available to trade. The company’s stock has a 5-day price change of -15.15% and -50.65% over the past three months. SGMO shares are trading -40.00% year to date (YTD), with the 12-month market performance up to 17.24% higher. […]
Sangamo Therapeutics Inc (NASDAQ: SGMO) Not A Good Play Anymore?
Sangamo Therapeutics Inc (SGMO) concluded trading on Wednesday at a closing price of $0.75, with 6.64 million shares of worth about $4.98 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -18.09% during that period and on April 23, 2025 the price saw a […]
Sangamo Therapeutics Inc (SGMO) Testing Investors’ Patience Right Now
Currently, there are 166.79M common shares owned by the public and among those 154.22M shares have been available to trade. Insiders at the company have transacted a total of 41 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 15 of these insider trades were purchases, […]
Handle With Care: Sangamo Therapeutics Inc (NASDAQ: SGMO)
Currently, there are 166.79M common shares owned by the public and among those 154.22M shares have been available to trade. Insiders at the company have transacted a total of 41 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 15 of these insider trades were purchases, […]
Sangamo Therapeutics Inc (NASDAQ: SGMO) Stock In Prove Me State
The Vanguard Group, Inc. has recently announced that it has increased stake in Sangamo Therapeutics Inc (NASDAQ:SGMO) by 1.13%. After grabbing 12.41 million shares, the institutional investor is now in possession of 0.14 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 7.00% having worth around $5.34 million. […]